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Abstract. 
 
Islets of Langerhans are microorgans scat-
tered throughout the pancreas, and are responsible for 
synthesizing and secreting pancreatic hormones. While 
progress has recently been made concerning cell differ-
entiation of the islets of Langerhans, the mechanism 
controlling islet morphogenesis is not known. It is 
thought that these islets are formed by mature cell asso-
ciation, first differentiating in the primitive pancreatic 
epithelium, then migrating in the extracellular matrix, 
and finally associating into islets of Langerhans. This 
mechanism suggests that the extracellular matrix has to 
be degraded for proper islet morphogenesis. We dem-
onstrated in the present study that during rat pancreatic 
development, matrix metalloproteinase 2 (MMP-2) is 
activated in vivo between E17 and E19 when islet mor-
phogenesis occurs. We next demonstrated that when 
E12.5 pancreatic epithelia develop in vitro, MMP-2 is 
activated in an in vitro model that recapitulates endo-
crine pancreas development (Miralles, F., P. Czerni-
chow, and R. Scharfmann. 1998. 
 
Development
 
. 125:
1017Ð1024). On the other hand, islet morphogenesis 
was impaired when MMP-2 activity was inhibited. We 
next demonstrated that exogenous TGF-
 
b
 
1 positively 
controls both islet morphogenesis and MMP-2 activity. 
Finally, we demonstrated that both islet morphogenesis 
and MMP-2 activation were abolished in the presence 
of a pan-specific TGF-
 
b
 
 neutralizing antibody. Taken 
together, these observations demonstrate that in vitro, 
TGF-
 
b
 
 is a key activator of pancreatic MMP-2, and that 
MMP-2 activity is necessary for islet morphogenesis.
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I
 
n
 
 the adult rat, the endocrine pancreatic tissue repre-
sents 2% of the pancreatic mass. This endocrine tissue
is composed of cells associated into spherical microor-
gans: the islets of Langerhans. These islets (around 5,000
per pancreas) contain a few thousand cells that express in-
sulin (beta cells), glucagon, somatostatin, or pancreatic
polypeptides. Beta cells are localized in the center of the
islets, while the other endocrine cells are localized in the
periphery.
During development, it is thought that precursor cells
that will give rise to pancreatic endocrine cells are present
in the primitive pancreatic duct epithelium where they dif-
ferentiate into endocrine cells (30). Once differentiated,
these cells will migrate into the interstitial matrix, and fi-
nally aggregate to form the islets of Langerhans (9). While
progress has recently been made concerning the early
steps of endocrine cell differentiation (1, 19, 40, 43), the
mechanism leading to islet morphogenesis remains poorly
understood. The focus of the present work is islet morpho-
genesis.
Cell migration of pancreatic endocrine cells through the
extracellular matrix (ECM)
 
1
 
 is thought to constitute an es-
sential step in islet morphogenesis (8, 9). In the pancreas
as in other organs, the major components of the ECM are
essentially collagens, laminins, and fibronectins. Enzymes
known to be able to degrade the different components of
the ECM are thus possibly implicated in endocrine cell mi-
gration.
Matrix metalloproteinases (MMPs) are a large family of
related proteolytic enzymes that include collagenases, ge-
latinases, and stromelysins. These enzymes have been im-
plicated in cancer cell invasion (45). MMPs have also been
implicated in the morphogenesis of a large number of
organs. Indeed, an appropriate balance between metallo-
proteinases and their inhibitors (the tissue inhibitors of
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metalloproteinases [TIMPs]), is necessary for proper mor-
phogenesis of the mammary gland (44), as well as for the
branching of salivary glands and ureter buds (21, 27).
Recently we have described an in vitro model that reca-
pitulates the development of the endocrine pancreas (24).
In this system, mature endocrine cells differentiate from
rat embryonic pancreatic epithelium cultured into tridi-
mensional collagen gels. Interestingly, once differentiated,
the endocrine cells organize with the characteristic archi-
tecture of islets of Langerhans, with beta cells in the center
and endocrine nonbeta cells in the periphery. Thus, in that
model, both morphogenesis and cytodifferentiation occur.
We have used this in vitro model to investigate the mecha-
nisms that lead to islet morphogenesis during early fetal
life. Our study indicates that (
 
a
 
) in vivo, MMP-2 is ex-
pressed in the pancreas, and its activity is maximum be-
tween E17 and E19 when islet morphogenesis is impor-
tant; (
 
b
 
) in vitro, MMP-2 activity is necessary for proper
islet morphogenesis, and is tightly controlled by TGF-
 
b
 
.
Thus TGF-
 
b
 
 plays an important role in islet morphogene-
sis, one of its targets being MMP-2.
 
Materials and Methods
 
Animals and Pancreatic Rudiments Dissection
 
Pregnant Wistar rats were purchased from Janvier breeding center (Le
Genet, France). The morning the vaginal plug was discovered was desig-
nated as embryonic day 0.5 (E0.5). Pregnant rats at 12.5 d of gestation
were killed by cervical dislocation, and the embryos were removed. Their
whole digestive tract was isolated and used to dissect the dorsal pancreatic
primordium (11). The pancreatic epithelium was prepared as previously
described (24). In brief, the dorsal pancreatic rudiment was incubated in a
0.03% collagenase A (Boehringer Mannheim Corp., Meylan, France) so-
lution in RPMI 1640 synthetic medium (GIBCO BRL, Eragny, France)
for 1 h at 37
 
8
 
C (18). The enzymatic digestion was stopped by a 30-min in-
cubation in a 1:1 mixture of RPMI 1640 medium and FCS. Thereafter, the
dorsal pancreatic epithelial bulge was freed of its surrounding mesen-
chyme using tungsten needles.
 
Culture of the Dorsal Pancreatic Epithelia in
Three-dimensional Collagen Gels
 
Dorsal pancreatic epithelia were grown in three-dimensional collagen
gels. The collagen gels were prepared according to Montesano et al. and
as previously described (24, 26). 200 
 
m
 
l of collagen were dispensed into 15-
mm wells of four-well plates and allowed to gel at 37
 
8
 
C. The pancreatic
epithelia were placed on the surface of the collagen gel and covered with
300 
 
m
 
l of collagen solution. After the second layer had gelled, 500 
 
m
 
l of
complete culture medium was added. The complete medium consisted of
RPMI 1640 supplemented with 10% heat-inactivated FCS, 2 mM
glutamine, 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin. In some ex-
periments, recombinant human TGF-
 
b
 
1 (R&D Systems Europe, Oxon,
United Kingdom) was added to the culture medium at a final concentra-
tion of 1 ng/ml. In other experiments, a pan-specific TGF-
 
b
 
 neutralizing
antibody (AB-100-NA; R&D Systems) was used at a final concentration
of 2 
 
m
 
g/ml. Rabbit preimmune sera was used as a control for the experi-
ences using the pan TGF-
 
b
 
 neutralizing antibody. The antibody was added
every day either from the first or third day of the culture. For perturbing
experiments, a stock solution (10 mM) of the metalloproteinases inhibitor
BB-3103 (British Biotechnology Pharmaceuticals, Ltd., Oxford, UK) was
prepared in DMSO. Working dilution of the inhibitor and comparable
DMSO controls were made in culture medium. Cultures were maintained
at 37
 
8
 
C in a humidified atmosphere of 95% air and 5% CO
 
2
 
. Medium was
replaced every 48 h. At the indicated times, the pancreatic epithelia were
photographed and fixed for immunohistology as described below.
 
Immunohistology
 
The pancreatic epithelia were fixed at 4
 
8
 
C in 4% paraformaldehyde in
PBS for 2 h, briefly rinsed with PBS, cryoprotected overnight at 4
 
8
 
C in
30% sucrose, and frozen. Consecutive sections (6 
 
m
 
m thick) were cut and
collected on gelatinized glass slides. For immunostaining, the sections
were first incubated for 30 min in PBS containing 3% BSA. Subsequently,
the sections were incubated for 2 h at room temperature (or overnight at
4
 
8
 
C) with the primary antibodies. After washing in PBST (PBS containing
0.5% Tween-20), the sections were incubated with the appropriate fluo-
rescent secondary antibodies. Finally, the sections were extensively
washed in PBST and mounted with a fluorescence protecting medium
(Vectashield, Vector Laboratories, Inc., Burlingame, CA). The sections
were examined and photographed with a Leitz DMRD microscope. Colo-
calization was determined by double-labeling immunofluorescence. For
this purpose, antibodies prepared in two different species were used and
revealed using anti-species antibodies labeled with two different fluoro-
chromes. Single-labeled sections incubated with mismatched secondary
antibodies showed no immunostaining, confirming the specificity of the
secondary antisera.
The antisera used in this study were used at the following dilutions:
guinea pig anti-porcine insulin (1:500; DAKO A/S, Glostrup, Denmark);
mouse monoclonal anti-porcine glucagon (1:2,000; Sigma Chemical Co.,
St. Louis, MO); rabbit anti-human amylase (1:2,000; Sigma Chemical Co.);
mouse monoclonal anti-human insulin (1:2,000; Sigma Chemical Co.); and
sheep anti-human MMP-2 (1:100; reference 15).
The fluorescent secondary antibodies were fluorescein anti-guinea pig
antibodies (1:500; DAKO A/S) and the following secondary antibodies
from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA): flu-
orescein anti-rabbit antibodies (1:200); fluorescein anti-mouse antibodies
(1:200); Texas red anti-rabbit antibodies (1:500); and Texas red anti-
mouse antibodies (1:200).
 
Quantitative Analysis
 
To determine the number of insulin-positive cells per pancreatic epithe-
lium, serial 6-
 
m
 
m sections were cut and collected on multiwell glass slides.
One out of two consecutive sections (that is, sections separated by 12 
 
m
 
m)
was analyzed by immunocytochemistry to avoid counting the same cell
twice. A mean of 50 
 
6 
 
5 sections was analyzed per rudiment. Only the im-
munoreactive cells for which a nucleus was clearly visible were counted.
The results of each experimental point were obtained by quantifying the
absolute number of each pancreatic cell type in at least five pancreatic ru-
diments. Data are presented as mean 
 
6 
 
SEM. Statistical analysis was per-
formed using a StudentÕs 
 
t
 
 test.
 
Reverse Transcriptase (RT) PCR Analyses
 
Total RNA was extracted from pancreatic rudiments (6) and reverse-tran-
scribed as previously described (3). In brief, first-strand cDNA was pre-
pared from DNase-treated RNA using random hexamer primers: 200 µM
each of dNTP, and 100 U of reverse transcriptase (SuperScript; Life Tech-
nologies, Inc., Grand Island, NY). The reaction was also carried out in the
absence of reverse transcriptase to ensure that the amplified material de-
rive from RNA. The oligonucleotides used for amplification were as follows:
MMP-2 (sense) 5
 
9
 
-TTACACACCTGACCTGGACCCT-3
 
9
 
;
MMP-2 (antisense) 5
 
9
 
-CGTTCCCATACTTACTCGGACC-3
 
9
 
;
MMP-9 (sense) 5
 
9
 
-GAGGGACGCTCCTATTTGTCCT-3
 
9
 
;
MMP-9 (antisense) 5
 
9
 
-GGGAAGACGCACATCTCTCCT-3
 
9
 
;
MT-MMP (sense) 5
 
9
 
-GGAATGACATCTTCTTGGTGGC-3
 
9
 
;
MT-MMP (antisense) 5
 
9
 
-TAGGTGGGGTTTCTGGGCTTAT-3
 
9
 
;
TIMP-1 (sense) 5
 
9
 
-GATATGTCCACAAGTCCCAGAACC-3
 
9
 
;
TIMP-1 (antisense) 5
 
9
 
-GCAGGCAAAGTGATCGCTCT-3
 
9
 
;
TIMP-2 (sense) 5
 
9
 
-CGGAAGGAGATGGCAAGATG-3
 
9
 
;
TIMP-2 (antisense) 5
 
9
 
-GCGCAAGAACCATCACTTCTCT-3
 
9
 
;
TIMP-3 (sense) 5
 
9
 
-AAAGAAGCTGGTGAAGGAAGGG-3
 
9
 
;
TIMP-3 (antisense) 5
 
9
 
-CTGGGACAGTGTGAGGTGGTC-3
 
9
 
;
TGF-
 
b
 
1 (sense) 5
 
9
 
-GACTCTCCACCTGCAAGACCAT-3
 
9
 
;
TGF-
 
b
 
1 (antisense) 5
 
9
 
-TCCCGAATGTCTGACGTATTGA-3
 
9
 
;
TGF-
 
b
 
2 (sense) 5
 
9
 
-CGCCCACTTTCTACAGACCCTA-3
 
9
 
;
TGF-
 
b
 
2 (antisense) 5
 
9
 
-GAGGTGCCATCAATACCTGCA-3
 
9
 
;
TGF-
 
b
 
3 (sense) 5
 
9
 
-GAAGAAGAGGGTGGAAGCCATT-3
 
9
 
;
TGF-
 
b
 
3 (antisense) 5
 
9
 
-GGTTCCATTTTTCTCCACTGAGG-3
 
9
 
;
TGF-
 
b
 
R1 (sense) 5
 
9
 
-TTTCAGAGGGCACCACCTTAAA-3
 
9
 
;
TGF-
 
b
 
R1 (antisense) 5
 
9
 
-CCATGCTCATGATAATCCGACA-3
 
9
 
;
TGF-
 
b
 
R2 (sense) 5
 
9
 
-AGAAGTGAAAGATTATGAGCCCCC-3
 
9
 
;
TGF-
 
b
 
R2 (antisense) 5
 
9
 
-GTGTTCAGGGAGCCGTCTTCT-3
 
9
 
;
Cyclophilin (sense) 5
 
9
 
-ATGGTCAACCCCACCGTGTT-3
 
9
 
;
Cyclophilin (antisense) 5
 
9
 
-CGTGTGAAGTCACCACCCT-3
 
9
 
. 
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30 cycles of amplification were performed. Amplification parameters in-
cluded a 1-min denaturation step at 94
 
8
 
C, a 1-min annealing step at 57
 
8
 
C,
and a 30-s extension step at 72
 
8
 
C. The products of amplification were sep-
arated on a 2% agarose gel, and were photographed.
 
Zymography
 
Tissue-associated and secreted metalloproteinases were detected and
characterized by zymography (14). This technique was applied to pools of
10 solubilized epithelia, and to concentrated media conditioned from
pools of 10 epithelia cultured for 24 h. The pancreatic rudiments were
directly lysed in SDS-PAGE sample buffer (50 mM Tris, 1% SDS, 5%
glycerol, 0.002% bromophenol blue). Concentrated conditioned media
was diluted in the same buffer. Then, the solubilized rudiments and con-
centrated media were loaded on 8% SDS-polyacrylamide gels copolymer-
ized with 1 mg/ml of gelatin (Sigma Chemical Co.). Electrophoresis was
performed under nonreducing conditions at 20 mA for 2 h at room tem-
perature. Gels were washed twice for 30 min in 2.5% Triton X-100 to re-
move SDS, incubated in substrate buffer (50 mM Tris-HCl, 5 mM CaCl
 
2
 
, 1
mM ZnCl
 
2
 
, pH 7.5) for 24 h at 37
 
8
 
C, stained in 0.5% Coomassie blue (pre-
pared in 30% ethanol, 10% acid acetic, 1% formaldehyde) for 30 min at
room temperature, and destained three times for 15 min in the same
buffer devoid of Coomassie blue. The presence of metalloproteinase was
indicated by an unstained proteolytic zone of the substrate. 
 
Results
 
Metalloproteinase Expression and Activity In Vivo 
during Pancreatic Development
 
Extracts of rat pancreas were examined by gelatin zymog-
raphy in order to identify metalloproteinase activity in the
pancreas at specific stages of development. A metallopro-
teinase of 72 kD, the precursor form of MMP-2 (15), was
detected at all the pancreatic stages analyzed. The levels of
this enzyme did not appear to change significantly over
time (Fig. 1 
 
A
 
). In contrast, a proteinase of 
 
z
 
66 kD, which
represents the activated form of the MMP-2, was detected
in extracts from E17 to E19 pancreases. By E19, the 66-kD
form of the enzyme represented roughly 50% of the total
enzyme present in the pancreas (Fig. 1 
 
A
 
). In the newborn
and adult pancreas, the enzyme was found only in its inac-
tive form (72 kD). No activity associated with the 92-kD
forms of MMP-9 was detected (Fig. 1 
 
A
 
). As shown in Fig.
1 
 
B
 
, the MMP activity present at E19 was inhibited by the
synthetic compound BB-3103, a hydroxamic acidÐbased in-
hibitor of proteases (2, 23). Inhibition of the gelatinase zy-
mograms was effective in the range of 50Ð1,000 
 
m
 
M (Fig. 1 
 
B
 
).
RT-PCR was used in a qualitative manner to determine
expression in the developing pancreas of the transcripts
encoding the different components of the metalloprotein-
ase system. MMP-2, MT1-MMP, TIMP-1, and TIMP-2
transcripts in the pancreatic rudiments were found to re-
main expressed throughout the entire pancreatic develop-
ment as well as in the adult pancreas (Fig. 2 
 
A
 
). This ob-
servation correlates well with the levels of expression of
the 72-kD form of the enzyme detected by zymography.
Similar results were obtained for expression of the tran-
scripts encoding MT1-MMP, the membrane activator of
MMP-2, and the metalloproteinase inhibitors TIMP-1 and
TIMP-2. To determine the cell types expressing MMP-2,
sections of fetal pancreas in the late stages of development
(E20) were labeled with sheep anti-human MMP-2 anti-
bodies, which recognize mice and rat MMP-2 (21). At that
stage, MMP-2 immunoreactivity was detected in insulin-
positive cells (Fig. 2 
 
B
 
). Indeed, a perfect colocalization
was found between insulin-immunoreactivity and MMP-
2-immunoreactivity.
 
Development of E12.5 Pancreatic Epithelia In Vitro
 
When E12.5 rat pancreatic epithelia were cultured into a
three-dimensional collagen gel, they rapidly acquired a
spherical shape. This spherical shape remained unchanged
during the first 4 d of culture (Fig. 3 
 
A
 
). During these first
4 d, differentiation into endocrine cells occurred. Indeed,
while very few endocrine cells were present before culture
(24), a considerable number of glucagon- and insulin-posi-
tive cells were detected by immunohistochemistry after 4 d
in culture. At that stage of culture, endocrine cells were
found into the central epithelial mass of the pancreatic ru-
diment, and did not associate to form typical islet struc-
tures (Fig. 3 
 
B
 
).
On the other hand, after 7 d in vitro as previously de-
scribed (24), a variable number of translucent structures
have emerged from the central epithelial sphere (Fig. 3 
 
C
 
).
The immunohistological analysis revealed that these trans-
lucent structures were constituted exclusively by endo-
crine cells with glucagon-positive cells present at the pe-
Figure 1. Metalloproteinases activity in the developing pancreas:
(A) Equal amounts of protein extracts from each of the stages in-
dicated were analyzed by zymography. A proteinase of 70Ð72 kD,
representing the proform of the enzyme MMP-2, was detected in
samples of all the stages of pancreatic development. The 62Ð64 kD
activated form of the enzyme is essentially detectable between
E17 and E19. (B) Protein extracts from E19 rat pancreas were
run on a 8% SDS-polyacrylamide gel copolymerized with 1 mg/ml
of gelatin. The gel was next divided into sections for subsequent
overnight digestion at 378C in incubation buffer (50 mM Tris,
10 mM CaCl2, pH 7.6) containing (a) no additive; (b) 10 mM
BB-3103; (c) 50 mM BB-3103; (d) 1 mM compound BB-3103; or
(e) 0.1 ml/ml DMSO diluent.The Journal of Cell Biology, Volume 143, 1998 830
riphery of large clusters of insulin-positive cells (Fig. 3 D).
Thus, in the present in vitro system, pancreatic epithelial
cells first differentiate into endocrine cells. Once differen-
tiated, these endocrine cells migrate away from the central
epithelial mass and associate into islets of Langerhans.
The distribution of the specific endocrine cells into the
round compact structures resembles the islets found in vivo.
Implication of MMP Activity in Islet Morphogenesis
In Vitro
As we have described that MMP-2 is activated in vivo in
the developing pancreas between E17 and E19, a period
where islets develop, we asked whether MMP-2 activity
was implicated in islet formation found in the in vitro
model described above. We first tested whether the differ-
ent components of the metalloproteinase system were
expressed in vitro. The RT-PCR analysis showed that
transcripts encoding the MMP-2 metalloproteinase, its
membrane-associated receptor MT1-MMP, and the inhibi-
tor/activators TIMP-1, TIMP-2, and TIMP-3, were ex-
pressed in the epithelia developed in culture for 4 d (Fig. 4
A). To define the cell types expressing MMP-2 in vitro, im-
munohistological analysis was performed using a sheep
anti-human MMP-2 antibody. As shown in Fig. 4 B, the
antibody reacted positively with the majority of the insu-
lin-positive cells present in pancreatic epithelia cultured
for 4 d. The remaining tissue stained negatively.
To further examine the role of MMPs in islet morpho-
genesis, perturbing experiments were performed. For that
purpose, the effect of the protease inhibitor BB-3103,
which as shown above inhibited MMP-2 activity present in
E19 pancreases, was tested in tissue culture. As shown in
Fig. 5 when pancreatic epithelia were cultured in the pres-
ence of 1 or 10 mM BB-3103, islet formation was impaired.
Indeed, endocrine structures fail to bud from the central
mass in the presence of the inhibitor (compare A to B and
C). On the other hand, cell differentiation was not im-
paired in the presence of the inhibitor. Indeed, immuno-
histological analysis showed that after 7 d in culture, dif-
ferentiation into insulin- or glucagon-expressing cells did
occur in the presence of the compound BB-3103 (Fig. 5,
DÐF). Differentiation into amylase-expressing cells did also
occur properly in the presence of inhibitor (Fig. 5, GÐI).
Moreover, quantification of the absolute number of endo-
crine and exocrine cells in the explants treated with 1Ð10
mM indicated that the absolute number of differentiated
cells was not significantly different from the one found in
control rudiments (Table I, A).
The effect of BB-3103 was fully reversible. Indeed, 2 d
after removing the compound BB-3103, endocrine struc-
tures started to bud from the core of the explants, and 3 d
later the explants showed the same appearance than the
control explants (data not shown).
As controls, pancreatic explants were cultured in the
presence of zinc metalloendopeptidases (thiorphan, 0.1
mM), serine proteases (aprotinin, 100 mg/ml), or cystein
proteinases (leupeptin, 10 mM). In these conditions, the
explants developed large endocrine buds identical to those
found in controls (data not shown).
TGF-b1 Positively Controls Both Islet Morphogenesis 
and MMP-2 Activity
TGF-b has been shown to play an important role in endo-
Figure 2. Expression of matrix metalloproteinase components in
the pancreas in development. (A) RT-PCR analysis of MMP-2,
MT1-MMP, TIMP-1, and TIMP-2 expression. First-strand cDNA
was synthesized and used as template in PCR reactions. 30 cycles
of amplification were performed for each reaction. (B) Sections
of newborn rat pancreas were costained with (a) anti-insulin and
(b) anti-MMP-2 antibodies.
Figure 3. Morphological and immunohistological analysis of pan-
creatic rudiments developed in vitro. Pancreatic rudiments de-
void of their surrounding mesenchyme were grown into tridimen-
sional collagen gels. Pancreatic rudiments were photographed (A
and C) and analyzed by immunohistochemistry (B and D) for in-
sulin (green) or glucagon (red) expression after 4 (A and B) and
7 d (C and D) of culture.Miralles et al. TGF-b and Pancreatic Islet Morphogenesis 831
crine pancreatic development (37). Since it has also been
shown that TGF-b controls MMP activities in different
models (22, 29, 31, 32, 34, 35, 48), we analyzed in vitro the
effect of TGF-b1 on both islet morphogenesis and MMP
activity. After 4 d in culture in the presence of TGF-b1,
translucent buds have already emerged, which was not the
case after 4 d in the absence of exogenous TGF-b1 (Fig. 6,
compare  A and B). In the TGF-b1Ðtreated rudiments,
many of the endocrine cells showed a spindled shape char-
acteristic of cells that are in migration (Fig. 6, compare C
and D). Islet morphogenesis thus occurs faster in the pres-
ence of TGF-b1 than in the absence of TGF-b1. During
the next 3 d the buds continue to develop (Fig. 6, E and
H). Note that in the presence of exogenous TGF-b1 after 7 d
in culture, the segregation between beta and nonbeta cells
was perturbed when compared with controls. Indeed, insu-
lin-positive cells were not surrounded by glucagon-posi-
tive cells (Fig. 6 H). Finally, when the total number of en-
docrine cells developed in the absence or in the presence
of TGF-b1 were counted after 4 or 7 d of culture, no signif-
icant difference was found between rudiments grown in
the presence or absence of TGF-b1, suggesting that exoge-
nus TGF-b1 treatment did not perturb cell differentiation
(Table I, B).
The next step was to compare the activity of metallopro-
teinases in pancreatic rudiments grown for 4 or 7 d in the
presence or absence of exogenous TGF-b1. Extracts of
pancreatic rudiments were analyzed by zymography. The
zymograms showed that a 72-kD band corresponding to
the inactive form of MMP-2 was present after both 4 and 7 d
of culture in rudiments grown in the presence or absence
of TGF-b (Fig. 7). However, while after 4 d in culture in
the absence of TGF-b1, no band corresponding to the acti-
vated form of MMP-2 was detected (Fig. 7, lane 1), such a
band was detected in rudiments developed for 4 d in the
presence of TGF-b1 (Fig. 7, lane 2). Finally, after 7 d of
culture, a band corresponding to the activated form of
MMP-2 was found in rudiments grown in the presence or
absence of exogenous TGF-b1. Similar results were ob-
tained when the concentrated conditioned media of pan-
creatic rudiments were analyzed by zymography (data not
shown). Thus, in the presence of TGF-b1, both islet mor-
phogenesis and MMP-2 activation are accelerated.
TGF-b Is Necessary for Islet Morphogenesis
Our results described above demonstrate that exogenous
TGF-b accelerates islet morphogenesis. However, islet
morphogenesis did also occur in the absence of exogenous
TGF-b after 7 d of culture. This formation of islets found
after 7 d of culture in the absence of exogenous TGF-b1
was also paralleled by an induction of MMP-2 activity
(Fig. 7, lanes 1 and 3). This result suggests that if TGF-b is
necessary for islet morphogenesis, (a) pancreatic epithelia
Figure 4. Expression of the matrix metalloproteinases compo-
nents in pancreatic rudiments in culture. (A) RT-PCR analysis of
MMP-2, MT1-MMP, and TIMPs 1Ð3 expression in pancreatic ru-
diments cultured for 4 d. First-strand cDNA was synthesized and
used as template in PCR reactions. 30 cycles of amplification
where performed for each reaction. (B) Immunohistochemical
analysis of insulin and MMP-2 expression in pancreatic rudi-
ments. Sections were costained with (a) anti-insulin and (b) anti-
MMP-2 antibodies.
Figure 5. Compound BB-3130 inhibits islet morphogenesis with-
out affecting cell differentiation. The rudiments were grown for
7 d in the absence (control) or in the presence of BB-3103 (1 mM
or 10 mM). Adding 1 mM or 10 mM of compound BB-3103 inhib-
its islet morphogenesis (compare A to B and C). On the other
hand, immunohistochemical analysis revealed that differentiation
into insulin-positive cells in green or into glucagon-positive cells
in red occured both in the absence (D) or in the presence (E and
F) of inhibitor. The differentiation into amylase-positive cells did
also occur in the absence (G) or in the presence (H and I) of
BB-3103.The Journal of Cell Biology, Volume 143, 1998 832
in culture should produce TGF-b and express TGF-b re-
ceptors; and (b) islet morphogenesis should not occur
when TGF-b activity is blocked.
RT-PCR analysis was used to define whether TGF-b
transcripts as well as transcripts encoding the receptors of
TGF-b were expressed in the in vitroÐcultured rudiments.
As shown in Fig. 8, predicted-size DNA fragments corre-
sponding to TGF-b1, TGF-b2, and TGF-b3 were ampli-
fied from pancreatic rudiments cultured for 4 d. More cy-
cles of amplification were necessary to amplify TGF-b1
than TGF-b2 or TGF-b3, suggesting that the level of ex-
pression of TGF-b1 was lower than that of TGF-b2 and
TGF-b3. TGF-b receptors (TGF-bRI and TGF-bRII)
could also be amplified from pancreatic epithelia cultured
for 4 d.
To further investigate the implication of endogenous
TGF-b in islet morphogenesis, pancreatic epithelia were
cultured in the presence of a pan-specific TGF-b neutraliz-
ing antibody. The antibody was added every day starting
either from the first day or from the third day of the cul-
ture. Both MMP-2 activation and islet morphogenesis
were followed. When the anti-TGF-b is added either from
day 0 or from day 3 of the culture and the zymography
performed at day 7, MMP-2 is found in its inactive form,
while in the absence of antibody, MMP-2 is found acti-
vated (Fig. 9). In the absence of neutralizing antibody, islet
morphogenesis occurred, the endocrine cells being found
outside of the central core of amylase-positive cells (Fig.
10, A and B). When the rudiments were cultured in the
presence of the anti-TGF-b neutralizing antibody from
day 3 to day 7, endocrine structures fail to bud from the
central mass, and remain surrounded by the amylase-posi-
tive cells (Fig. 10, C and D) in a way identical to that found
when the rudiments were grown in the presence of the
metalloproteinase inhibitor BB-3101 (compare Fig. 5, E
and H to Fig. 10, C and D). When the rudiments were cul-
tured in the presence of the anti-TGF-b neutralizing anti-
body from day 0 to day 7, the endocrine cells did not mi-
grate away from the central epithelial sphere either. They
were found dispersed in the central core of the rudiments
(Fig. 10, E and F), suggesting that during the first days of
culture, TGF-b plays a role in endocrine cell adhesion. It is
also clear that when the antibody was added from day 0 to
day 7, cells negative for insulin, glucagon, and amylase
were frequently found in the rudiment, a fact that was
found neither in control rudiments nor in rudiments
treated with the antibody from day 3 to day 7. Finally, the
quantitative analysis showed that the absolute number of
either endocrine or exocrine cells was not affected by the
panTGF-b neutralizing antibody (Table I, C and D).
Discussion
This work presents novel observations with respect to the
morphogenesis of the islets of Langerhans of the pancreas.
First, we have demonstrated that induction of MMP-2 ac-
tivity is necessary for proper morphogenesis of the islets of
Figure 6. Morphological and immunohistological analysis of pan-
creatic rudiments developed in vitro in the presence of exoge-
nous TGF-b1. Pancreatic rudiments devoid of their surrounding
mesenchyme were grown into tridimensional collagen gels in the
absence (A, C, E, and G) or in the presence (B, D, F, and H) of
TGF-b1. Pancreatic rudiments were photographed and analyzed
by immunohistochemistry for insulin (green) or glucagon (red)
expression after 4 (AÐD) and 7 d (EÐH) of culture. Note that af-
ter 4 d in culture in the presence of TGF-b1, translucent buds
were already emerging (B), and many endocrine cells showed a
spindled shape characteristic of cells that are in migration (D),
which was not the case after 4 d in the absence of exogenous
TGF-b1.
Table I. Quantitative Analysis of Pancreatic Development
In Vitro
Experience
Average cell number/pancreatic rudiment
n Endocrine Exocrine
A
Control 1,900 6 100 
NS
900 6 80 
NS
5
BB-3103 1,800 6 90 836 6 100 8
B
Control 1,900 6 100 
NS
940 6 110 
NS
10
TGF-b1 1,700 6 80 1,150 6 100 10
C
Control 1,800 6 100 
NS
1,000 6 120 
NS
11
Anti-TGF-b (d0Ðd7) 1,500 6 200 1,400 6 100 16
D
Control 1,600 6 200 
NS
1,100 6 250 
NS
5
Anti-TGF-b (d3Ðd7) 1,700 6 100  2,000 6 300 5
Quantification of the number of endocrine and exocrine cells developed in the pancre-
atic rudiments grown in vitro. The absolute number of endocrine and exocrine cells
developed in the pancreatic rudiments was determined by counting respectively the
number of endocrine cells (insulin- and glucagon-immunoreactive cells) and the num-
ber of exocrine cells (amylase-immunoreactive cells). The data represent the mean 6
SEM. n 5 number of pancreatic rudiments analyzed per experience.Miralles et al. TGF-b and Pancreatic Islet Morphogenesis 833
Langerhans. Second, we have shown that TGF-b is a key
activator of MMP-2 in the islets, and that inhibition of
TGF-b activity represses islet morphogenesis.
During development, the pancreas forms as an epithelial
evagination of the foregut endoderm into the surrounding
mesenchyme (39). Putative stem cells present in the epi-
thelium will next differentiate into exocrine or endocrine
cells. The differentiated endocrine cells will migrate away
from the primitive epithelium into the surrounding mes-
enchyme and aggregate into microorgans: the islets of
Langerhans. Mouse aggregation chimera experiments
have confirmed this model of development, and have
shown that islets are not derived from a few cells that pro-
liferate, but through aggregation of endocrine cells inter-
spersed in the interstitial tissue (9). Thus, cell migration
through the ECM represents an essential step for proper
morphogenesis of the endocrine islets.
In different models, cell migration requires ECM degra-
dation. Among the enzymes implicated in ECM degrada-
tion, the collagenase metalloproteases MMP-2 and MMP-9
have focused our attention, since these proteases have
been implicated in morphogenetic events associated with
organogenesis. For example, MMP-2 and -9 are thought to
contribute to morphogenesis of the tongue and Meckel
cartilage during mandibule arch development (5). MMP-9
has also been shown to be necessary for branching mor-
phogenesis of the ureter bud (21). MMP-2 also focused
our attention because it is implicated not only in the deg-
radation of the ECM, but also in cell migration by provid-
ing a signal for cell migration initiation (10). MMP activity
is known to depend on a complex balance between MMPs,
their cell surface activators (MT-MMPs), and their inhibi-
tors (TIMPs; 45). Our study clearly establishes that MMP-2,
MT1-MMP, and various TIMPs are expressed through the
entire pancreatic development. However, zymographic
studies show that the activated form of MMP-2 is essen-
tially detectable between E17 and E19, a period when en-
docrine cells leave the primitive epithelium, migrate, and
associate into the well-defined architecture of adult islets
(13, 25, 47). Between E17 and E19, MMP-2 could thus be
implicated in degradation of the ECM, which is at that
stage mainly composed of collagen types -I, -III, and -IV
(16). This degradation step would be necessary to allow
endocrine cells to migrate into the ECM.
To investigate further the eventual implication of MMPs
in islet morphogenesis, we have used a recently described
in vitro model of pancreatic development (24). Pancreatic
epithelium prepared from E12.5 rat pancreatic rudiments
was cultured in a tridimensional collagen. In these condi-
tions, the pancreatic epithelium differentiates essentially
into endocrine cells (24). As shown in the present study,
differentiation occurs in the central epithelial mass. Once
differentiated, the cells migrate into the collagen gel and
associate into microorgans, which resemble islets of Lang-
erhans found in vivo after birth (28). Thus, this in vitro
model mimics the in vivo process of islet morphogenesis,
and can thus be used to understand how islet morphogene-
sis occurs.
Our perturbing experiments performed using the com-
pound BB-3101, a hydroxamic acidÐbased inhibitor of pro-
teases (2, 23), demonstrate that when MMP-2 activity is
blocked, endocrine cell differentiation occurs normally,
while islet morphogenesis is abolished. This result demon-
strates that morphogenesis is not necessary for endocrine
cell differentiation. This last result is not unexpected since
it has been shown that pancreatic cytodifferentiation can
Figure 7. Analysis of gelatinase
expression and activity in pan-
creatic rudiments cultured in the
presence of exogenous TGF-b1.
Pancreatic rudiments grown for
4 or 7 d in the presence or ab-
sence of TGF-b were analyzed
for MMP-2 activity by gel zy-
mography. Lanes 1 and 2: pan-
creatic rudiment grown for 4 d
without (lane 1) or with (lane 2)
1 ng/ml TGF-b1. Lanes 3 and 4: pancreatic rudiment grown for
7 d without (lane 3) or with (lane 4) 1 ng/ml TGF-b1.
Figure 8. Expression of TGF-b and its receptors in pancreatic ru-
diments in culture. cDNAs were prepared from pancreatic rudi-
ments devoid of mesenchyme and cultured for 4 d in collagen
gels. Then they were used as template in PCR reactions with spe-
cific primers for TGF-b1, TGF-b2, TGF-b3, TGF-bRI, and TGF-
bRII. (A) 30 cycles of amplification. (B) 35 cycles of amplification.
Figure 9. Analysis of gelatinase A expression and activity in pan-
creatic rudiments grown in the presence of a panTGF-b neutral-
izing antibody. The pancreatic rudiments were cultured in the
presence of a panTGF-b neutralizing antibody, and after a 7-d
culture period, the rudiments were recovered and their gelatinase
activity was analyzed by gel zymography. The antibody was
added either from the third (A) or from the first (B) day of cul-
ture. (2) rudiments cultured in the presence of nonimmune se-
rum; (1) rudiments cultured in the presence of the TGF-b neu-
tralizing antibody.The Journal of Cell Biology, Volume 143, 1998 834
occur in the absence of morphogenesis. Indeed, when em-
bryonic pancreatic epithelium is cultured in conditions
that do not favor pancreatic morphogenesis, cytodifferen-
tiation takes place (41). Moreover, during pancreatic de-
velopment, endocrine cell differentiation is found before
pancreatic morphogenesis (12).
Our results also demonstrate that TGF-b is a strong ac-
tivator of MMP-2 activity. In other models, TGF-b1 usu-
ally increases matrix component production, decreases
proteinase activities, and increases proteinase inhibitors
synthesis (31, 32, 48). But there are also some examples in
which TGF-b displays an stimulating effect on MMP-2 (22,
29) or MMP-9 activities (34, 35). When pancreatic rudi-
ments were cultured in the presence of TGF-b1, the timing
of MMP-2 activation and islet morphogenesis were accel-
erated when compared with controls, suggesting that
TGF-b1 acts as an activator of ECM degradation. At that
point of the discussion, it is of interest to consider the sta-
tus of the ECM in transgenic animals overexpressing
TGF-b in beta cells. Indeed, in these transgenic animals,
increased deposition of ECM was observed (20, 38). These
results seem to be in partial contradiction with the data
presented here. However, the results obtained in trans-
genic animals are difficult to compare with the data pre-
sented here, because (a) abnormal deposition of ECM
could in fact be due to an increase in ECM synthesis and
not to a decrease in ECM degradation; and (b) in the
transgenic model, progressive accumulation of ECM was
observed only after birth, no embryonic/fetal phenotype
being found.
In the present study, TGF-b was found to be an activa-
tor of islet morphogenesis. Indeed, adding exogenous
TGF-b accelerates islet formation. However, islet mor-
phogenesis did also occur in the absence of exogenously
added TGF-b, suggesting that endogenously produced
TGF-b could be implicated in islet morphogenesis. We
demonstrate that: (a) TGF-b1, -b2, and -b3 are produced
in the present experimental system; and (b) islet morpho-
genesis is abolished when a specific panTGF-b neutraliz-
ing antibody is added to the culture medium. The demon-
stration of TGF-b production by pancreatic cells confirms
previous data demonstrating that in mice, TGF-b1 mRNA
is present in pancreatic buds throughout development
(38), and that TGF-b1, -b2, and -b3 are synthesized in the
endocrine and exocrine human pancreas (46). However,
the fact that a panTGF-b neutralizing antibody abolished
islet morphogenesis was not totally expected. Indeed, it
does demonstrate that TGF-b is necessary for islet mor-
phogenesis. To our knowledge, no such drastic effect of
TGF-b on morphogenesis induction has been described up
to now. Islet morphogenesis does thus represent a key
model to understand how TGF-b controls morphogenesis.
While a panTGF-b neutralizing antibody perturbed islet
morphogenesis, endocrine cell differentiation was not af-
fected. The lack of effect of TGF-b on endocrine cell dif-
ferentiation is in concordance with data obtained in trans-
genic mice that overexpress TGF-b1 in beta cells and have
a normal number of endocrine cells (20, 38). It seems,
however, in contradiction with other studies showing that
in vitro TGF-b1 influences the relative proportion of the
exocrine and endocrine pancreas (37). In this latter study,
the experimental system was quite different from the one
used here. Indeed, pancreatic embryonic epithelia were
grown in the presence of their surrounding mesenchyme,
while we did use mesenchyme-depleted epithelium. How-
ever, in the work of Sanvito et al. (37), TGF-b treatment
modified the shape and arrangement of stromal cells, and
the authors postulated that one possibility would be that
some of the effects of TGF-b1 on epithelial cells could in
fact be indirect and secondary to changes in the extracellu-
Figure 10. Analysis of pan-
creatic rudiments grown in
the presence of a panTGF-b
neutralizing antibody. To de-
fine whether TGF-b is neces-
sary for islet formation, pan-
creatic rudiments were
cultured in the presence of a
pan-specific TGF-b neutral-
izing antibody. The antibody
was added either from the
first (d0) or the third (d3) day
of the culture. The rudi-
ments were analyzed by im-
munohistochemistry for insu-
lin, glucagon, and amylase
expression. In the control ru-
diments, the insulin- (green)
and glucagon- (red) express-
ing cells are arranged into is-
let-like structure (A), bud-
ding from the core of the
rudiment that is mainly composed of amylase-expressing cells (B). When the rudiments are cultured in the presence of the panTGF-b
neutralizing antibody from the third day of culture (d3Ðd7), the endocrine cells differentiate, but do not bud (C), and form small clusters
interspersed between the acinar cells (D). When the rudiments are cultured in the presence of the panTGF-b neutralizing antibody from
the first day of culture (d0Ðd7), a more drastic effect is observed. The endocrine cells appear dispersed (E) and surrounded by acinar
cells (F).Miralles et al. TGF-b and Pancreatic Islet Morphogenesis 835
lar matrix through effects on stromal cells (37). Such a hy-
pothesis could be right and could represent an explanation
of the difference in endocrine cell numbers between our
work and the work of Sanvito et al. (37).
In addition to its role in activating MMP-2 and inducing
islet morphogenesis, we demonstrate that TGF-b has
some additional effects. First, when an excess of TGF-b is
added, while islet morphogenesis is accelerated, the final
three-dimensional organization of the different endocrine
cell types is perturbed. In this case, insulin-positive cells
are not surrounded by glucagon-positive cells as in normal
islets (28). Second, when the rudiments are grown in the
presence of a neutralizing TGF-b antibody, the treatment
starting from the beginning of the culture (i.e., before cell
differentiation had occurred) islet morphogenesis and en-
docrine cell adhesion are perturbed. Some effects on cell
differentiation could also be seen in those conditions. No
such effects are seen when the antibody is added while cell
differentiation has already started. The effect of TGF on
cell adhesion could be mediated by regulating N-CAM
with TGF-b. Indeed, N-CAM has been proposed as being
implicated in pancreatic endocrine cell adhesion (7), and
TGFs control N-CAM expression in different experimen-
tal systems (33, 42). The effect of TGF-b on cell differenti-
ation observed when the neutralizing antibody is added at
the beginning of the culture resemble s the one described
when a dominant-negative TGF-b type II receptor is ex-
pressed in transgenic mice in acinar cells (4). Indeed, we
found cells staining negative for insulin, glucagon, and
amylase. These cells could represent acinar cells that dedif-
ferentiate into cells with a ductal phenotype as previously
proposed (4).
Recently, TGF-b1, TGF-b2, and TGF-b3 knockout
mice have been generated (17, 36). To our knowledge, no
overt pancreatic phenotype has been described in those
animals. This fact can be explained either by the fact that
the pancreas was not analyzed in great detail, or by the
fact that isoform redundancy among the three TGF-bs iso-
forms masks the effect. In fact, the latter hypothesis is
plausible because all three TGF-b family members are
found to be expressed in the pancreas (46, the present work).
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